Lucid Diagnostics Inc. (LUCD)
NASDAQ: LUCD · IEX Real-Time Price · USD
0.930
-0.020 (-2.14%)
At close: May 3, 2024, 4:00 PM
0.975
+0.045 (4.87%)
After-hours: May 3, 2024, 7:52 PM EDT
Lucid Diagnostics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Lucid Diagnostics stock have an average target of 3.17, with a low estimate of 2.50 and a high estimate of 4.00. The average target predicts an increase of 240.97% from the current stock price of 0.93.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for LUCD stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +168.90% | Apr 12, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $3.8 → $3 | Buy | Maintains | $3.8 → $3 | +222.68% | Mar 27, 2024 |
| Needham | Needham | Strong Buy Reiterates $2.5 | Strong Buy | Reiterates | $2.5 | +168.90% | Mar 27, 2024 |
| Needham | Needham | Strong Buy Maintains $2.8 → $2.5 | Strong Buy | Maintains | $2.8 → $2.5 | +168.90% | Nov 14, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $4 | Buy | Reiterates | $4 | +330.25% | Sep 26, 2023 |
Financial Forecast
Revenue This Year
6.34M
from 2.43M
Increased by 161.29%
Revenue Next Year
18.07M
from 6.34M
Increased by 184.85%
EPS This Year
-0.98
from -1.26
EPS Next Year
-0.80
from -0.98
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 8.3M | 38.3M | 94.3M | 151.3M | 181.6M |
| Avg | 6.3M | 18.1M | 46.8M | 120.9M | 152.9M |
| Low | 4.6M | 6.9M | 17.6M | 91.0M | 124.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 242.3% | 503.6% | 421.7% | 223.5% | 50.2% |
| Avg | 161.3% | 184.9% | 158.9% | 158.4% | 26.5% |
| Low | 88.3% | 8.1% | -2.4% | 94.6% | 2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.97 | -0.62 | 0.08 | -0.40 | -0.11 |
| Avg | -0.98 | -0.80 | -0.45 | -0.39 | -0.10 |
| Low | -1.06 | -0.86 | -0.74 | -0.37 | -0.10 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.